Ventyx biosciences to participate in three upcoming investor conferences

San diego, nov. 12, 2024 (globe newswire) -- ventyx biosciences, inc. (nasdaq: vtyx) (“ventyx”, “company”), a clinical-stage biopharmaceutical company focused on advancing novel oral therapies that address a broad range of inflammatory diseases with significant unmet medical need, today announced that company executives will participate in the following upcoming investor conferences:

VTYX Ratings Summary

VTYX Quant Ranking